China Evergrande Group 中國恒大集團

Andrew Edward Left v SFC & MMT
HK Court of Final Appeal, 14-Jul-2020
Leave to appeal is dismissed.
Court of Appeal dismisses Andrew Left's leave applicationJudgment
SFC, 24-May-2019
The only option left to Mr Left is to apply for leave to the Court of Final Appeal.
Court of Appeal dismisses appeal by Andrew LeftJudgment
SFC, 26-Feb-2019
Andrew Edward Left v SFC & MMT
HK Court of Appeal, 25-Feb-2019
Cross-Harbour (0032) coughs up details of investments
Company announcement, 27-Sep-2018
This follows a complaint to SEHK by Webb-site. It emerges that the company at 30-Jun-2018 held HK$584.2m of shares in China Evergrande (0333) and HK$396.1m of shares in Evergrande Health (0708). Other investments of HK$1903m remain unidentified.
China Evergrande (3333) top at giving away shareholders' money
South China Morning Post, 13-Oct-2017
The company donated RMB1,608m in 2016, or about 9.1% of net profit. It's difficult to see how such largesse can be consistent with the board's fiduciary duty to shareholders.
Court of Appeal dismisses leave application of Andrew Left on MMT's findings of fact
SFC, 13-Jan-2017
His appeal on points of law will be dealt with separately.
Andrew Left and the right to be wrong
We take a close look at the Market Misconduct Tribunal's report on Mr Left's erroneous criticism of China Evergrande (3333), and what that says about free speech amongst participants in the HK market. (23-Oct-2016)
SFAT's red flag on Moody's chills negative research
We look at what the SFAT's ruling and the SFC's action says about the future of Hong Kong as a place in which freedom of debate and negative criticism is becoming increasingly difficult. (8-Apr-2016)
MMT dismisses application by Andrew Left of Citron Research
SFC, 2-Nov-2015
This battle will be fought on the public information of Evergrande, and whether no reasonable analyst could reach the opinion that Evergrande was insolvent as Mr Left did, the publication of which the SFC alleges was false and misleading information. The question is, if his opinions were so inconsistent with the facts, then why would anyone take them seriously? Analysts are allowed to be wrong. The fact that their opinions move prices does not mean the opinion is always right.
MMT sets hearing date on alleged false research report
SFC, 19-Mar-2015
A date 11 months away - is the MMT that busy?
SFC actions risk chilling critics
A New Year's Eve SFAT ruling reveals an SFC action against Moody's for its 2011 "red flags" report, following the recent launch of MMT action against a short-selling analyst. The SFC risks chilling publication of critical opinion and analysis - something we would hate to stop doing. We will be watching the cases carefully. (1-Jan-2015)
SFC takes Citron Research head to MMT over Evergrande (3333) reports277, SFO.
SFC, 22-Dec-2014
This should be interesting. The SFC will need to show that Andrew Left either knew that his allegations were false or was reckless or negligent as to whether they were, in which case Section 277 of the SFO bites.
The SFC's notice to the MMMT re Citron's report on Evergrande (3333)
Market Misconduct Tribunal, 15-Dec-2014

Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top